Carisma Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Carisma Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2014 to Q2 2024.
  • Carisma Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 6, 2024 was 41.5M shares, a 3.13% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 41.5M +1.26M +3.13% Aug 6, 2024 10-Q 2024-08-08
Q1 2024 41.5M -162M -79.6% Mar 15, 2024 10-K 2024-04-01
Q3 2023 40.4M -162M -80.1% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 40.3M -159M -79.8% Aug 9, 2023 10-Q 2023-08-10
Q1 2023 203M +4.03M +2.02% Feb 21, 2023 10-K 2023-02-28
Q3 2022 203M +3.29M +1.65% Oct 31, 2022 10-Q 2022-11-07
Q2 2022 199M +3.46M +1.77% Aug 1, 2022 10-Q/A 2022-08-25
Q1 2022 199M +31.9M +19% May 2, 2022 10-Q 2022-05-09
Q3 2021 199M +70.1M +54.2% Nov 1, 2021 10-Q 2021-11-08
Q2 2021 196M +78.8M +67.3% Aug 2, 2021 10-Q 2021-08-09
Q1 2021 168M +57.6M +52.4% Mar 8, 2021 10-K 2021-03-15
Q3 2020 129M +24.7M +23.6% Nov 2, 2020 10-Q 2020-11-09
Q2 2020 117M +15.9M +15.7% Aug 3, 2020 10-Q 2020-08-10
Q1 2020 110M +32.5M +42% Feb 29, 2020 10-K 2020-03-16
Q3 2019 105M +27.2M +35.1% Nov 7, 2019 10-Q 2019-11-12
Q2 2019 101M +24.3M +31.5% Aug 6, 2019 10-Q 2019-08-08
Q1 2019 77.5M +34.4M +79.7% Feb 27, 2019 10-K 2019-03-01
Q3 2018 77.5M Nov 7, 2018 10-Q 2018-11-09
Q2 2018 77M +52.3M +212% Aug 10, 2018 10-Q 2018-08-14
Q1 2018 43.1M +18.4M +74.5% Mar 30, 2018 10-K 2018-04-02
Q4 2017 31.8M Nov 15, 2017 10-Q 2017-11-17
Q2 2017 24.7M +4.64M +23.1% Aug 11, 2017 10-Q 2017-08-14
Q1 2017 24.7M +5.02M +25.5% Mar 23, 2017 10-K 2017-03-24
Q3 2016 24.2M +4.65M +23.7% Oct 31, 2016 10-Q 2016-11-14
Q2 2016 20.1M +679K +3.5% Jul 31, 2016 10-Q 2016-08-12
Q1 2016 19.7M +313K +1.62% Mar 15, 2016 10-K 2016-03-25
Q3 2015 19.6M +3.3M +20.2% Oct 31, 2015 10-Q 2015-11-04
Q2 2015 19.4M +3.11M +19.1% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 19.4M +3.11M +19.1% Apr 17, 2015 10-Q 2015-04-30
Q3 2014 16.3M Nov 6, 2014 10-Q 2014-11-13
Q2 2014 16.3M Aug 8, 2014 10-Q 2014-08-13
Q1 2014 16.3M May 12, 2014 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.